Cargando…

Sicherheit der Sars-CoV-2-Vakzine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478101/
https://www.ncbi.nlm.nih.gov/pubmed/32922251
http://dx.doi.org/10.1007/s11298-020-8035-4
_version_ 1783579997504536576
collection PubMed
description
format Online
Article
Text
id pubmed-7478101
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-74781012020-09-09 Sicherheit der Sars-CoV-2-Vakzine CME (Berl) Therapie Aktuell Springer Medizin 2020-09-16 2020 /pmc/articles/PMC7478101/ /pubmed/32922251 http://dx.doi.org/10.1007/s11298-020-8035-4 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Therapie Aktuell
Sicherheit der Sars-CoV-2-Vakzine
title Sicherheit der Sars-CoV-2-Vakzine
title_full Sicherheit der Sars-CoV-2-Vakzine
title_fullStr Sicherheit der Sars-CoV-2-Vakzine
title_full_unstemmed Sicherheit der Sars-CoV-2-Vakzine
title_short Sicherheit der Sars-CoV-2-Vakzine
title_sort sicherheit der sars-cov-2-vakzine
topic Therapie Aktuell
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478101/
https://www.ncbi.nlm.nih.gov/pubmed/32922251
http://dx.doi.org/10.1007/s11298-020-8035-4